Evidence Hub

Recent Advances in Quantum Computing for Drug Discovery and Development

Pei-Hua Wang, Jen-Hao Chen, Yu-Yuan Yang, Chien-shiun Lee, Y. Tseng

IEEE Nanotechnology Magazine, 2023

74 citations

Abstract

Drug discovery and development is a time-consuming and cost-intensive process. Computer-aided drug design can speed up the timeline and reduce costs by decreasing the number of necessary biochemical experiments. The number of studies using quantum computing to solve problems in drug development has been increasing in recent years. In this review, we briefly introduce the main steps in drug discovery and development and how computers help to find potential drug candidates. Recent studies of quantum computing in drug development based on the structure of target proteins are listed chronologically. They include protein structure prediction, molecular docking, quantum simulation, and quantitative structure-activity relationship (QSAR) models. Current quantum devices are still susceptible to noise and error but are well suited for hybrid quantum-classical algorithms. The quantum advantage is demonstrated on hybrid systems and quantum-inspired devices such as quantum annealers. We hope to see more applications of quantum computing in the field of drug discovery and development.

How strong is the evidence?

Evidence Hub reads this as a review, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free